AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+1.48%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$12.3B
AUM Growth
+$966M
(+8.6%)
Cap. Flow
+$856M
Cap. Flow
% of AUM
6.99%
Top 10 Holdings %
Top 10 Hldgs %
51.59%
Holding
825
New
217
Increased
182
Reduced
275
Closed
151
Top Buys
| 1 |
BWP
Boardwalk Pipeline Partners
BWP
|
+$136M |
| 2 |
Enterprise Products Partners
EPD
|
+$114M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$65.8M |
| 4 |
Brookfield
BN
|
+$39.8M |
| 5 |
Baxter International
BAX
|
+$33.1M |
Top Sells
| 1 |
Cheniere Energy
CQP
|
+$81.9M |
| 2 |
GG
Goldcorp Inc
GG
|
+$33M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$23.8M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$19.4M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$14.9M |
Sector Composition
| 1 | Energy | 66.36% |
| 2 | Materials | 2.69% |
| 3 | Financials | 2.67% |
| 4 | Healthcare | 2.57% |
| 5 | Technology | 1.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
NVIDIA
NVDA
$4.1T
| $592K | ﹤0.01% |
+345,320
| New | +$592K |
|
252
Lear
LEA
$6B
| $590K | ﹤0.01% |
+4,866
| New | +$590K |
|
|
RVNC
253
DELISTED
Revance Therapeutics, Inc.
RVNC
| $589K | ﹤0.01% |
36,313
-3,677
| -9% | -$59.6K |
|
254
Hormel Foods
HRL
$14B
| $585K | ﹤0.01% |
+15,418
| New | +$585K |
|
255
Biogen
BIIB
$20.7B
| $575K | ﹤0.01% |
1,836
-228
| -11% | -$71.4K |
|
|
CELG
256
DELISTED
Celgene Corp
CELG
| $568K | ﹤0.01% |
5,430
-626
| -10% | -$65.5K |
|
257
Home Depot
HD
$418B
| $561K | ﹤0.01% |
4,357
+936
| +27% | +$121K |
|
258
Douglas Emmett
DEI
$2.83B
| $559K | ﹤0.01% |
15,273
-728
| -5% | -$26.6K |
|
259
Highwoods Properties
HIW
$3.45B
| $544K | ﹤0.01% |
10,428
-500
| -5% | -$26.1K |
|
260
Texas Instruments
TXN
$169B
| $541K | ﹤0.01% |
7,714
-145
| -2% | -$10.2K |
|
261
Citigroup
C
$176B
| $539K | ﹤0.01% |
+11,414
| New | +$539K |
|
262
Intel
INTC
$114B
| $529K | ﹤0.01% |
14,024
-10,496
| -43% | -$396K |
|
|
OMED
263
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $523K | ﹤0.01% |
45,747
+3,185
| +7% | +$36.4K |
|
264
InterDigital
IDCC
$7.74B
| $519K | ﹤0.01% |
6,552
-1,058
| -14% | -$83.8K |
|
265
Celldex Therapeutics
CLDX
$1.52B
| $518K | ﹤0.01% |
8,545
-700
| -8% | -$42.4K |
|
|
GIMO
266
DELISTED
Gigamon Inc.
GIMO
| $511K | ﹤0.01% |
+9,332
| New | +$511K |
|
|
NDRM
267
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $510K | ﹤0.01% |
27,598
-2,814
| -9% | -$52K |
|
268
JetBlue
JBLU
$1.85B
| $508K | ﹤0.01% |
29,486
+6,904
| +31% | +$119K |
|
269
General Motors
GM
$55.4B
| $506K | ﹤0.01% |
15,916
-765
| -5% | -$24.3K |
|
270
Adeia
ADEA
$1.68B
| $505K | ﹤0.01% |
49,612
-2,053
| -4% | -$20.9K |
|
271
Southwest Airlines
LUV
$16.7B
| $505K | ﹤0.01% |
12,998
+2,751
| +27% | +$107K |
|
|
IDTI
272
DELISTED
Integrated Device Technology I
IDTI
| $504K | ﹤0.01% |
21,837
+1,833
| +9% | +$42.3K |
|
273
Nike
NKE
$110B
| $502K | ﹤0.01% |
9,527
+76
| +0.8% | +$4.01K |
|
274
Rayonier Advanced Materials
RYAM
$403M
| $499K | ﹤0.01% |
+37,340
| New | +$499K |
|
275
Texas Pacific Land
TPL
$21B
| $498K | ﹤0.01% |
+6,360
| New | +$498K |
|